A new Tel Aviv University study finds that treating a primary tumor with combining genetic therapy with chemotherapy delivered to a primary tumor site is extremely effective in preventing breast cancer metastasis. The breakthrough research was led by Dr. Noam Shomron of TAU’s Sackler School of Medicine in collaboration with Dr. Natalie Artzi of the Massachusetts Institute of Technology. The study was published in the Nature Communications. One in eight women worldwide are diagnosed with breast cancer during their lifetimes.
Breast cancer is the second leading cause of cancer death in women. The chance that a woman will die from breast cancer is about 1 in 36. Early detection, while increasingly common, is not sufficient to preventing metastasis, the lethal movement of cancerous cells from a primary tumor site to colonies in vital organs. About 80 percent of women with metastatic cancer die from the disease within just five years of being diagnosed. READ MORE
